Does the use of insulin faster aspart vs. aspart lead to the prolonged glycemic time in range in children with type 1 diabetes who use continuous glucose monitoring?

被引：0
|
作者：
Kowalczyk-Korcz, E. [1 ]
Dyminska, M. [1 ]
Szypowska, A. [1 ]
机构：
[1] Med Univ Warsaw, Dept Pediat Diabetol & Pediat, Warsaw, Poland
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2024年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-75
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [41] Compatibility and safety of faster-acting insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes
    Zijlstra, Eric
    Demissie, Marek
    Graungaard, Tina
    Heise, Tim
    Nosek, Leszek
    Bode, Bruce W.
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 46 - 46
  • [42] Faster-acting insulin aspart: faster offset of exposure and action in addition to faster onset in subjects with type 1 diabetes using continuous subcutaneous insulin infusion
    Zijlstra, E.
    Heise, T.
    Nosek, L.
    Rikte, T.
    Haahr, H.
    DIABETOLOGIA, 2016, 59 : S98 - S99
  • [43] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
  • [44] Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial
    Home, PD
    Lindholm, A
    Riis, A
    DIABETIC MEDICINE, 2000, 17 (11) : 762 - 770
  • [45] Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring
    Pettus, Jeremy
    Edelman, Steven V.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : 34 - 42
  • [46] Insulin aspart versus insulin lispro via continuous subcutaneous insulin infusion (CSII) in children and adolescents with type 1 diabetes
    Weinzimer, Stuart
    Laffel, Lori
    Ternand, Christine
    Howard, Campbell
    Chang, C. T.
    Becker, Dorothy
    DIABETES, 2007, 56 : A478 - A478
  • [47] COMPARISON OF POST-EXERCISE GLUCOSE EXCURSIONS AFTER USE OF INSULIN GLULISINE AND INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES
    Tanaka, N.
    Hiura, Y.
    Kuwata, H.
    Watanabe, K.
    Hyo, T.
    Yabe, D.
    Kurose, T.
    Seino, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S75 - S75
  • [48] A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial
    Dovc, Klemen
    Bergford, Simon
    Froehlich-Reiterer, Elke
    Zaharieva, Dessi P.
    Potocnik, Nejka
    Mueller, Alexander
    Lenarcic, Ziva
    Calhoun, Peter
    Fritsch, Maria
    Sourij, Harald
    Bratina, Natasa
    Kollman, Craig
    Battelino, Tadej
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (09) : 612 - 621
  • [49] Insulin aspart improves long-term glycaemic control in Type 1 diabetes - A randomized trial vs. human insulin
    Home, PD
    Lindholm, A
    Riis, A
    DIABETOLOGIA, 1999, 42 : A17 - A17
  • [50] HYBRID CLOSED-LOOP WITH FASTER INSULIN ASPART COMPARED WITH STANDARD INSULIN ASPART IN VERY YOUNG CHILDREN WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTICENTRE, RANDOMISED, CROSSOVER STUDY
    Ware, J.
    Allen, J.
    Boughton, C.
    Cezar, A.
    Hartnell, S.
    Wilinska, M.
    Thankamony, A.
    Deakin, M.
    Leyland, H.
    Phelan, K.
    Thornborough, K.
    Hovorka, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A56 - A56
12345